• Explore /
  • Poster
  • / Results of a multicenter, randomized, phase 3 trial of trimodality therapy with I-125 brachytherapy, external beam radiation therapy, and long- versus short-term androgen deprivation therapy for localized high-risk prostate cancer (TRIP/TRIGU0907).

Results of a multicenter, randomized, phase 3 trial of trimodality therapy with I-125 brachytherapy, external beam radiation therapy, and long- versus short-term androgen deprivation therapy for localized high-risk prostate cancer (TRIP/TRIGU0907).

Abstract Poster

Authors

null

Atsunori Yorozu

National Hospital Organization Tokyo Medical Center, Tokyo, Japan

Atsunori Yorozu , Mikio Namiki , Shiro Saito , Shin Egawa , Hiroshi Yaegashi , Konaka Hiroyuki , Tetsuo Momma , Takashi Fukagai , Nobumichi Tanaka , Toshio Ohashi , Hiroyuki Takahashi , Atsushi Mizokami , Yoko Nakagawa , Takashi Kikuchi , Nelson Stone

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Therapeutics

Clinical Trial Registration Number

UMIN000003992

Citation

J Clin Oncol 41, 2023 (suppl 6; abstr 305)

DOI

10.1200/JCO.2023.41.6_suppl.305

Abstract #

305

Poster Bd #

A3

Abstract Disclosures

Similar Posters

First Author: Ryan Phillips

First Author: Adam S. Kibel

First Author: Soumyajit Roy

First Author: Vinayak Muralidhar